Skip to main content
Screener/Healthcare/Biotechnology

RXRX — Recursion Pharmaceuticals, Inc.

NASDAQ
$3.54+0.04 (+1.14%)
Mid CapPenny StockUnder $5Healthcare
$2.77
$5.24
$3.48
$3.65
EPS (TTM)$-1.20
P/E Ratio-2.79
Dividend Yield—
Market Cap$2.41B
Volume12.30M
Prev Close$3.50
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$6.5M-$117.5M$-0.22-93.0%-1815.6%
Q4 '25$35.5M-$108.1M$-0.2124.4%-304.2%
Q3 '25$5.2M-$162.3M$-0.36-471.8%-3135.3%
Q2 '25$19.1M-$171.9M$-0.41-5.5%-899.8%
Q1 '25$14.7M-$202.5M$-0.50-48.0%-1373.3%
Q4 '24$4.5M-$178.9M$-0.53-183.6%-3966.0%
Q3 '24$26.1M-$95.7M$-0.3453.7%-366.8%
Q2 '24$14.4M-$97.5M$-0.4036.1%-677.2%
Get Your Daily Market Recap